# Role of Tau in Microtubule Stability in Adult Neurons

> **NIH NIH R21** · DREXEL UNIVERSITY · 2021 · $416,438

## Abstract

PROJECT SUMMARY / ABSTRACT
Tau, a fibrous microtubule-associated protein concentrated in the axon, binds to microtubules, thereby
influencing its properties. For decades, the prevailing theory has been that tau stabilizes microtubules in the
axon. This is based on test tube studies showing that excess tau can indeed stabilize microtubules, as well as
overexpression studies showing this to be the case in non-neuronal cells as well. Disease researchers are so
invested in the idea of tau as a microtubule stabilizer that work is underway to use microtubule-stabilizing drugs
to treat diseases such as Alzheimer’s, in which tau loses its association with microtubules. Recent published
work of the Principal Investigator has challenged this dogma, building on evidence that tau is enriched on the
labile domains of microtubules in the axon than on the stable domains. Moreover, in that work, when tau was
depleted from the neuron with RNA interference, there was a loss of microtubule mass but not due to
destabilization of the stable domains of the microtubules. Rather, there was a preferential loss of the labile
domains, with the remaining portion of the labile domains actually becoming more stable rather than less stable.
Additional studies suggested that tau prevents the labile domain from becoming stable by outcompeting genuine
microtubule-stabilizers such as MAP6, and also promotes the assembly of the labile domain. This is a strikingly
different scenario from the one that has become so established in the scientific literature, and potentially
transformational to both the basic sciences and medical sciences of tau. However, all of that work was done on
developing rodent neurons in culture, with the very real possibility that the situation is not the same in adult brain.
In this proposal, the Principal Investigator seeks to test whether the findings hold true in adult mouse brain, using
viral-driven RNA interference to lower tau levels. From there, studies are proposed to delve into the proposed
competition between tau and genuine microtubule stabilizers such as MAP6 by ectopically expressing
fluorescently tagged versions of them in non-neuronal cells in which binding of these proteins to microtubules
can be readily visualized. Collectively, these studies will contribute significantly to understanding of tau, a crucial
protein for both normal functioning of the axon and for disease, and will open the door toward mechanism-based
therapies to rectify the ill effects of tau loss-of-function in disease.

## Key facts

- **NIH application ID:** 10214857
- **Project number:** 1R21AG068597-01A1
- **Recipient organization:** DREXEL UNIVERSITY
- **Principal Investigator:** PETER W. BAAS
- **Activity code:** R21 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $416,438
- **Award type:** 1
- **Project period:** 2021-04-15 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10214857

## Citation

> US National Institutes of Health, RePORTER application 10214857, Role of Tau in Microtubule Stability in Adult Neurons (1R21AG068597-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10214857. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*